SLG
TWST icon

Stanley-Laman Group’s Twist Bioscience TWST Stock Holding History

Stanley-Laman Group’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-200,851
Closed -$7.08M – 247
2022
Q3 		$7.08M Buy
200,851
+166,233
+480% +$7.06M 1.34% 12
2022
Q2 		$1.21M Buy
+34,618
New +$1.23M 0.22% 147

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Stanley-Laman Group's TWST Position: Q4 2022 in Review

Stanley-Laman Group sold out of Twist Bioscience (TWST) in Q4 2022, closing a stake of 200,851 shares — an estimated $7.08M sold.

Stanley-Laman Group first reported a position in TWST in Q2 2022 and held it in 2 quarters. The position peaked at $7.08M in Q3 2022. 198 funds tracked by Wall St. Rank hold TWST as of Q4 2022.

  • Stanley-Laman Group reported no remaining Twist Bioscience position as of Q4 2022 after selling out during the quarter.
  • Stanley-Laman Group sold 200,851 Twist Bioscience shares in Q4 2022, an estimated $7.08M.
  • Stanley-Laman Group first reported a position in Twist Bioscience in Q2 2022 and held it in 2 quarters.
  • Stanley-Laman Group's Twist Bioscience position peaked at $7.08M in Q3 2022.
  • 198 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2022.

Based on Stanley-Laman Group's 13F filing for Q4 2022, filed 19 Jan 2023.